Phillips-Medisize, a US-based Molex company, has announced the expansion of its global manufacturing footprint, along with extended product design, development and manufacturing capabilities to streamline the delivery of game-changing products and solutions.

To address growing production demands from customers in continental Europe, Phillips-Medisize is building a state-of-the-art medical manufacturing facility in Katowice, Poland. Slated to open in 2022, the site will complement production sites and innovation centers in Asia, Europe, India, Mexico and North America.

Phillips-Medisize also is expanding production capacity in Suzhou, China to serve both global and regional pharmaceutical and MedTech customers.

Additionally, the transformation of an existing Molex production facility in Little Rock, Ark., is underway, enabling Phillips-Medisize to keep pace with ever-increasing requirements in the U.S. for high-volume, diagnostic device manufacturing.